Heather Callahan joined CU Innovations at Anschutz Medical Center in 2017 focused on strategically managing and operationalizing the therapeutic portfolio. Her career at Anschutz began in 2013, when she began working for the Gates Center for Regenerative Medicine as Director of Intellectual Property, and she continues to support the Gates Center as Entrepreneur in Residence.
Prior to joining Anschutz, Heather started her own consulting company, Divetank Strategies, LLC, through which she works primarily with local small biotech companies guiding them through formation, business and regulatory strategy, and intellectual property alignment. Before relocating to Colorado, Heather was the Head of Patent Development for Intellectual Ventures’ Invention Development and resided in Asia. She also worked at two biotech companies in California, Hollis-Eden Pharmaceuticals, Inc. and Genset Corporation, after beginning her law career at Lyon & Lyon, LLP. Before her legal career, she was a Research Scientist in infectious disease leading teams focused on mechanisms of drug resistance and drug discovery at the Walter Reed Army Institute of Research in the US and Brazil.
Heather earned an Executive MBA from the Daniels School of Business at Denver University, a J.D. from the University of San Diego School of Law, and completed a Post-Doc at Harvard Medical School after earning her Ph.D. in Biochemistry from the Medical University of South Carolina and a B.A. in Biology from Tufts University.